Boston Scientific | BSX - Fremdkapital

Aktienkurs
58.99
Täglich Wechseln
-0.96 -1.60%
Monatlich
-6.26%
Jährlich
-42.58%
Q2 Prognose
60.74




Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
AtriCure USD 61.86M 0 2025-12
Avanos Medical USD 90.3M 3.1M 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 11.01B 19M 2025-12
CONMED USD 853.01M 28.1M 2025-09
Cooper Companies USD 1.88B 578.5M 2025-12
Danaher USD 17.56B 855M 2026-03
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 600M 1.7M 2026-03
Globus Medical USD 436K 9K 2025-12
Illumina USD 1.49B 496M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.53B 1.91B 2026-03
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12